With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could ...

Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...

Insulin device maker Insulet Corporation (NASDAQ ... The analyst maintains the Outperform rating. Price Action: PODD stock is down 7.35% at $185.11 at last check on Friday.

Part B generally covers pumped insulin and the pump that delivers the drug when ... Medicare Part B will pay 20% of the Medicare-approved cost for diabetes self-management supplies such as glucose ...

Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...

Hundreds of lawsuits allege that insulin manufacturers and pharmacy benefit managers colluded to raise prices. The ...